Organ Transplant Immunosuppressant Drugs Is Fastest Growing Segment Fueling The Growth Of Organ Transplant Market
Organ Transplant Immunosuppressant Drugs Market Organ transplant immunosuppressant drugs are administered to prevent graft rejection in organ transplant recipients. These drugs help suppress the recipient's immune system and prevent it from attacking and rejecting the transplanted organ. The need for organ transplant procedures and immunosuppressant drugs is rising globally due to the increasing prevalence of organ failures. The global Organ Transplant Market is estimated to be valued at US$ 5.17 Bn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The organ transplant immunosuppressant drugs market is witnessing rising demand for modified-release drugs with improved pharmacokinetic profiles. Growing incidences of late acute rejection of organ grafts are also driving development of newer small molecules and biologics. Furthermore, technological a...